Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update

Affiliations

¹ Division of Endocrinology, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
² Division of Endocrinology, Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
³ Divisions of Internal Medicine, Clinical Epidemiology, and Endocrinology and Metabolism, Department of Medicine; Centre for Outcomes Research and Evaluation, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
⁴ School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
⁵ Banting & Best Diabetes Centre, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
⁶ Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Medicine and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
⁷ Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
⁸ Division of Endocrinology and Metabolism, University of Alberta, Edmonton, Alberta, Canada.

Review

Diabetes Canada Clinical Practice Guidelines Expert Committee et al. Can J Diabetes. 2020 Oct.

. 2020 Oct;44(7):575-591.

doi: 10.1016/j.jcjd.2020.08.001.

¹ Division of Endocrinology, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
² Division of Endocrinology, Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
³ Divisions of Internal Medicine, Clinical Epidemiology, and Endocrinology and Metabolism, Department of Medicine; Centre for Outcomes Research and Evaluation, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
⁴ School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
⁵ Banting & Best Diabetes Centre, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
⁶ Division of Endocrinology and Metabolism, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Medicine and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
⁷ Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
⁸ Division of Endocrinology and Metabolism, University of Alberta, Edmonton, Alberta, Canada.

No abstract available

Comment in

Pioglitazone and Lower Risk of Dementia: Will This Change Practice?
Maxwell CJ, Alkabbani W, Yasar S. Maxwell CJ, et al. Neurology. 2023 Apr 25;100(17):803-804. doi: 10.1212/WNL.0000000000207182. Epub 2023 Feb 15. Neurology. 2023. PMID: 36792376 No abstract available.